πŸ‡ΊπŸ‡Έ FDA
Patent

US 11608346

Ras inhibitors

granted A61PA61P35/00

Quick answer

US patent 11608346 (Ras inhibitors) held by Revolution Medicines, Inc. expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Revolution Medicines, Inc.
Grant date
Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P35/00